Financials

News Discussions Technicals Seasonals

Diluted net income available to common stockholders of CHA VACCINE RESEARCH INSTITUTE

Annual data

2020

2021

2022

2023

2024

TTM

‪‪−20.00 B‬‬

‪‪−15.00 B‬‬

‪‪−10.00 B‬‬

‪‪−5.00 B‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−10.39 B‬‬

+‪‪20.72 M‬‬

+‪0.20‬%

2024

‪‪−10.41 B‬‬

‪‪−8.66 B‬‬

‪−495.25‬%

2023

‪‪−1.75 B‬‬

+‪‪4.97 B‬‬

+‪73.95‬%

2022

‪‪−6.72 B‬‬

+‪‪11.70 B‬‬

+‪63.54‬%

2021

‪‪−18.42 B‬‬

‪‪−12.18 B‬‬

‪−195.18‬%

2020

‪‪−6.24 B‬‬

‪‪−3.26 B‬‬

‪−109.39‬%

Quarterly data

Q2 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−6.00 B‬‬

‪‪−4.00 B‬‬

‪‪−2.00 B‬‬

‪0.00‬

‪‪2.00 B‬‬

Period

Value

Change

Change %

Q4 '24

‪‪−4.41 B‬‬

‪‪−2.54 B‬‬

‪−135.26‬%

Q3 '24

‪‪−1.87 B‬‬

+‪‪817.86 M‬‬

+‪30.38‬%

Q2 '24

‪‪−2.69 B‬‬

‪‪−1.27 B‬‬

‪−89.95‬%

Q1 '24

‪‪−1.42 B‬‬

‪‪−3.16 B‬‬

‪−181.25‬%

Q4 '23

‪‪1.74 B‬‬

+‪‪3.82 B‬‬

—

Q3 '23

‪‪−2.07 B‬‬

‪‪−2.34 B‬‬

‪−859.27‬%

Q2 '23

‪‪272.84 M‬‬

+‪‪1.97 B‬‬

—

Q1 '23

‪‪−1.70 B‬‬

‪‪−160.07 M‬‬

‪−10.43‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q2 '21